生物样本库市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPBT00002331
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 230
Buy Now

市场洞察

全球生物样本库市场在 2021 年产生 24.1831 亿美元,预计到 2028 年将达到 37.5864 亿美元,2021 年复合年增长率为 6.5%。 2028。

用于研究疾病的资金和基因组研究活动的不断增长、制药和生物制药研发费用的增加以及再生医学的不断采用是促进生物样本库市场增长的潜在因素。相反,自动化的高成本阻碍了全球生物样本库市场的扩张。

生物样本库提供生物样本(例如血液)以及医疗数据的收集。生物库可能很大,包含数千个样本,也可能很小,仅包含几百个样本。不同的生物样本库收集不同的样本和信息来评估特定的功能。主要市场参与者通过多种有机和无机增长战略优化了其增长。

从地区来看,北美在全球生物样本库市场中占据最大份额,并且很可能在预测期内保持其主导地位。据推测,亚太地区在预测期内复合年增长率最高。

COVID-19 影响

 采样、分析和疫苗研制中的应用有助于全球生物样本库市场增长

全球 COVID-19 大流行对世界各地的医疗保健、经济和社会产生了深远的影响。北美的医疗保健系统在估计 COVID-19 影响的人口统计方面面临着迫在眉睫的问题。在大流行的早期阶段,加拿大的生物样本库活动被认为是非必要的医疗保健服务,但随着研究业务的出现,与疾病相关的研究被允许并发表。美国利用虚拟护理和远程监控策略来确保患者获得全面的临床支持。在大流行期间,生物样本库成为一项必要的服务,促进了更快的关键研究操作。全球生物样本库必须购买额外的个人防护装备(PPE)套件,以保护医务人员免受感染。此外,他们还在全球范围内沟通,以获取收集和存储样本所需的材料。

在欧洲,生物银行被证明对缓解 COVID-19 非常有帮助,因为它们为研究人员提供了必要的样本来评估情况和制造疫苗和疗法。生物样本库在大流行期间的研究、采样和疫苗接种方面发挥了至关重要的作用。如果没有从感染患者身上收集样本,就不可能让整个科学界都能获取 SARS-CoV-2 病毒的基因组并在创纪录的时间内生产出疫苗。受到道德困境和基础设施挑战困扰的亚太生物样本库市场未来可能会快速增长。印度医学研究委员会 (ICMR) 批准了 16 个生物样本库,用于收集、存储和保存新冠病毒感染患者的临床样本。

未来趋势

虚拟生物样本库

虚拟存储库提供从传统生物库中存储的样本中提取和表征的数据。虚拟生物银行的数据库提供样本的高分辨率图像和其他特征数据。这些生物库可以通过专门的软件或门户网站访问。它们允许访问记录的数据格式,无需物理样本。虚拟生物库通常用于生物信息学,包含有价值的临床活检标本的 2D 和 3D 显微镜数据集。该系统已成为提高样品可见性和访问的实用选择。研究人员可以使用虚拟生物样本库来识别他们所需的产品和服务,以简化和管理生物样本库流程的关键阶段。虚拟系统集成未来可能会推动全球生物样本库市场的发展。

驱动因素

用于研究疾病的资金和基因组研究活动不断增加

基因组测序正在迅速转型在政府大量投资的帮助下进入临床实践和医疗保健系统。国家基因组医学计划正在推动医疗系统的变革。英国宣布了世界上最大的基因组项目,作为慈善机构和制药公司之间 2 亿公私合作的一部分。该项目将资助研究人员和行业将英国卫生服务的数据和现实证据结合起来。总部位于马萨诸塞州的 Boston 公司获得了 430 万美元的种子资金,与基因组测序公司 Veritas Genetics 合作。生物样本库一直是传染病和宿主基因组研究的重要资源。来自生物样本库的数据有助于了解基因突变引起的多因素疾病的病因。

再生医学的采用不断增加

再生疗法有助于诱导细胞、组织和器官的再生,以恢复其功能。功能。美国食品和药物管理局(FDA)每年都会收到大量用于人体临床试验的再生医学申请。再生医学的快速进步为慢性病提供了有效的解决方案,可能推动全球生物样本库市场的增长。细胞疗法是再生医学领域增长最快的领域之一。诺华 Kymriah 是第一个治疗 B 细胞急性白血病的细胞治疗解决方案。生物样本库一直是再生医学的主要资产,因为它为研究、开发和治疗提供材料。投资生物样本库可以带来可观的成本回收,以支持再生医学和组织工程计划。

限制

自动化成本高

昂贵的自动化一直是主要障碍促进全球生物样本库市场的增长。先进的特性和功能使得生物样本存储仪器的价格很高。此外,由于生物样本库运营的成本不仅限于自动化,因此公司需要评估影响其整体财务稳定性的各种因素。自动化的总支出包括购买设备、其他基础设施以及根据需求进行流程改进的成本。自动化系统一开始的成本可能是手动操作的五到十倍。对于完全维护的自动化,十年运营成本预计在 0.57 美元至 566 万美元之间。研究公司正在为自动化整合支付更多费用。这种昂贵的自动化系统可能会限制全球生物样本库市场的增长。

战略见解

市场细分

按产品和服务划分

< h3>存储和处理的要求刺激了细分市场的增长

全球生物样本库市场按产品和服务分为设备、消耗品、服务和软件。设备领域在 2021 年占据了最大的市场份额,并将继续占据主导地位直到 2028 年。设备在生物样本库产品的制造中发挥着至关重要的作用。它在存储的每个阶段都至关重要。因此,生物材料的储存、处理和研究管理需要不同类型的设备。该细分市场进一步分为存储、样品分析、样品处理和样品运输设备。

消耗品是第二大市场吸引者,预计在预测期内将以最高的复合年增长率增长。样品采集、制备、分析、储存和运输的每个步骤都会用到培养皿、试管、移液器和烧杯等消耗品。此外,在质量控制过程中也需要它们以确保适当的测试。细分市场的增长很大程度上适应了研究和学术机构以及生命科学公司消耗品的使用。

生物样本库市场,按产品和服务划分 - 2021年和2028年

按样本分析

抽样和分析要求强化了该细分市场的主导地位

根据样本,全球生物样本库市场分为血液制品、人体组织、细胞系等。 2021年,血液制品领域以最大的收入份额主导市场,预计2021年至2028年将以最高复合年增长率飙升。血液是人类生物库中最常见的生物样本之一,是 DNA 和 RNA 的来源。人类生物样本的生物样本库需要血沉棕黄层和全血样本。

细胞系细分市场紧随血液制品占据第二大市场份额。患者来源的细胞系对于基础研究、高通量药物筛选和新药物评估至关重要。生物样本库在干细胞研究中维持人类胚胎干细胞系的作用至关重要。许多细胞系本质上是独特的,例如,从唐氏综合症患者获得的诱导多能干细胞。

区域见解

从地理上看,全球生物样本库市场分为北美、欧洲、亚太地区 (APAC)、南美和北美中美洲 (SCAM)、中东和非洲非洲 (MEA)。

北美在 2021 年占有最大的市场份额,预计到 2028 年将保持主导地位。医疗保健行业高度结构化、突破性产品较早被接受、慢性病盛行、医疗保健领域的突破药物发现、政府和非政府组织投资的增加以及关键参与者的存在是推动区域生物样本库市场的潜在参数。在美国,再生医学研究变得更加集中和先进,使疾病逆转成为可能。据观察,干细胞具有治疗多种以前被认为无法治疗的疾病的潜力。研究机构的扩大、学生和研究人员对各种基因研究的兴趣日益浓厚、全球公司的投资以及政府举措是推动加拿大生物样本库市场增长的主要因素。

亚太地区生物样本库市场可能会随着以下因素而扩大:预测期内复合年增长率最高。生物样本库是旨在保存生物资源和数据以供该地区未来研究和开发的众多举措之一。作为政府协调战略计划的一部分,中国尤其积极开展生物样本库活动。该国还提前建立了亚洲生物样本库网络,以确保资源和专业知识共享。为了建立稳定的运营体系,亚太地区的生物银行标准化了运营流程并实现了资金来源的多元化。印度政府资助转化研究机构治疗各种疾病,使国家更具创新性和可持续性。

生物样本库市场利润丰厚的地区

主要市场参与者:

  • Thermo Fisher Scientific Inc(美国)
  • Tecan Trading AG(瑞士)
  • QIAGEN(荷兰)
  • Hamilton Company (美国)
  • Avantor, Inc(美国)
  • Micronics Japan Co., Ltd.(日本)
  • BD(美国)
  • Taylor-Wharton(美国)
  • Brooks Automation, Inc(美国)
  • Biovault Family(英国)
  • Promega Corporation(美国)
  • < li>SciSafe Inc.(美国)

主要进展:

  • 2021 年 12 月:Thermo Fisher Scientific Inc. 收购了全球领先的 PPD, Inc.临床研究服务,价值 174 亿美元。
  • 2021 年 8 月:Tecan 集团完成对美国 Paramit Corporation 及其附属公司的收购,总收购价为 10 亿美元。< /li>
  • 2022 年 1 月:QIAGEN 宣布为 QI Acuity 不断增加的应用程序增加新功能,QI Acuity 是其超灵敏数字 PCR 平台,使用纳米板在短短两小时内处理样品。
  • 2021 年 7 月:BD收购了 Tepha Inc.,这是一家领先的可吸收聚合物专有技术开发商和制造商。

报告覆盖范围

全球生物样本库市场研究报告提供了对以下市场的详细见解:规模、份额、趋势和预测。它提供了关于驱动因素、限制因素、机会、细分市场和产业格局的清晰而精确的专业知识。我们讨论了 COVID-19 影响分析以及在全球和区域市场中观察到的机会。一些主要市场参与者及其近年来各自的发展已被保留为特别提及。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the COVID 19 impact on the biobanks market in the coming years?

Biobanking became a necessary service as a result of this development, allowing for faster COVID-19 research and the continuation of critical research operations. During the epidemic, navigating the scarce and frequently competing healthcare supply chains was critical for continuous operational demands. Global biobanks have had to purchase extra personal protective equipment (PPE) to safeguard their personnel from COVID-19, and even employees have had to be regularly checked for suspected COVID-19 symptoms. Biobanks had to communicate and search globally for the materials they required to quickly collect and store specimens. Biobanks are critical in collecting and preserving bio samples such as plasma, serum, DNA and RNA, clinical data, and genomic data due to the large number of clinical trials related to COVID-19.

Which region is expected to witness significant demand for the biobanks market in the coming years?

Global biobanks market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. North America held the largest market share for biobanks in 2021. The United States held the largest market in North America for biobanks, and the market is expected to grow due to the increasing adoption of technological advancements and rising innovations in regenerative medicine are projected to accelerate the growth of the biobanks market.

Which are the top companies that hold the market share in the biobanks market?

Hamilton Company. and Avantor, Inc. are the top two companies that hold huge market shares in the Biobanks market.

Who are the key players in the biobanks market?

The biobanks market majorly consists of players such Thermo Fisher Scientific Inc., Tecan Trading AG, QIAGEN, Hamilton Company, Avantor, Inc., Micronics Japan Co.,Ltd., BD, Taylor-Wharton, Brooks Automation, Inc., Biovault Family, Promega Corporation, and SciSafe Inc. amongst others.

Which application held the largest share in the biobanks market?

The regenerative medicine segment dominated the global biobanks market and accounted for the largest market share of 48.92% in 2021.

What is the market CAGR value of the biobanks market during the forecast period?

The CAGR value of the biobanks market during the forecasted period of 2021-2028 is 6.5%.

Which product and service led the biobanks market?

The equipment segment held the largest share of the market in the global biobanks market and held the largest market share of 54.38% in 2021.

Which sample held the largest share in the biobanks market?

The blood products segment dominated the global biobanks market and accounted for the largest market share of 75.47% in 2021.

What is a biobank?

A biobank is a collection of biological samples (such as blood) as well as health data. Biobanks might be vast, including thousands of samples, or small, containing only a few hundred. Different sorts of samples and information are collected by different biobanks. The information and samples gathered are determined by the biobank's specific function. The term biobank covers collections of plants and animals, including human specimens.

What are the driving factors for the biobanks market across the globe?

Key factors that are driving the growth of this market are the growing funding and genomic research activities for studying diseases, increasing pharmaceutical and biopharmaceutical R&D expenditures, and rising adoption of regenerative medicines are expected to boost the market growth for the biobanks over the years.

The List of Companies - Biobanks Market

  1. THERMO FISHER SCIENTIFIC INC.                 
  2. Tecan Trading AG               
  3. QIAGEN   
  4. Hamilton Company            
  5. Avantor, Inc.         
  6. MICRONICS JAPAN CO., LTD.         
  7. BD            
  8. Taylor-Wharton   
  9. Brooks Automation, Inc    
  10. Biovault Family    
  11. Promega Corporation       
  12. SciSafe Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports